Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
May 21, 2026
Rare Diseases Today—May 21, 2026
May 21, 2026
Cell and Gene Therapy Today—May 21, 2026
May 20, 2026
Lucid Diligence Brief: Endologix’s Pounce Acquisition
May 20, 2026
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal
May 20, 2026
Neuroscience Today—May 20, 2026
May 20, 2026
Immunology Today—May 20, 2026
May 20, 2026
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines
May 19, 2026
Obesity Today—May 19, 2026
May 19, 2026
Endocrinology Today—May 19, 2026
May 18, 2026
Oncology Today—May 18, 2026
May 18, 2026